Imeik Technology Development (SHE:300896) obtained drug registration from China's medical products administrator for its botulinum toxin injection product, according to a Thursday filing with the Shenzhen bourse.
The neurotoxin, also known as botox, is used cosmetically for wrinkles and medically for migraines, spasticity, overactive bladder and movement disorders.
Shares of the biomedical products manufacturer rose 3% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments